Danaher Corp
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher High-Growth Markets Revenue by Year
High-Growth Markets (China, India, Latin America, Eastern Europe, Middle East) Revenue — Consolidated ($M)
Danaher High-Growth Markets Revenue: $7,022M in FY2025, up 2.2% from a year earlier.
Where the FY2025 figure comes from
Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | High-Growth Markets (China, India, Latin America, Eastern Europe, Middle East) Revenue — Consolidated ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,022 | +2.2% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 6,870 | -4.5% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 7,191 | -6.7% | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 7,709 | -0.8% | Danaher SEC 10-K (FY2024, filed 2025-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 7,770 | – | Danaher SEC 10-K (FY2023, filed 2024-02-21) ↗ |
Breakdown
What makes up high-Growth Markets Revenue
- Biotechnology — High-Growth Markets (China, India, Latin America, Eastern Europe, Middle East)1,976 · FY2025
- Life Sciences — High-Growth Markets (China, India, Latin America, Eastern Europe, Middle East)2,124 · FY2025
- Diagnostics — High-Growth Markets (China, India, Latin America, Eastern Europe, Middle East)2,922 · FY2025
Cite this data
StockData. (2026). Danaher High-Growth Markets Revenue ($M), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-total-geo-hgm
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.